Table 1
Patient demographics
| Control group | Enalapril group | p Value | |
| Number | 15 | 15 | |
| Age (years) | 66.7 (1.8) | 62.7 (2.3) | 0.179 |
| Sex (male/female) | 13/2 | 13/2 | 1.000 |
| Hypertension | 7 | 8 | 1.000 |
| Current smoker | 1 | 3 | 0.591 |
| Total cholesterol (mmol/l) | 4.93 (0.21) | 5.28 (0.23) | 0.266 |
| Blood pressure | |||
| Before | |||
| Systolic (mmHg) | 126.7 (4.0) | 135.9 (5.0) | 0.161 |
| Diastolic (mmHg) | 70.6 (2.4) | 82.3 (2.3) | 0.020 |
| After 16 weeks | |||
| Systolic (mmHg) | 127.8 (5.8) | 130.5 (5.9) | 0.754 |
| Diastolic (mmHg) | 70.1 (3.7) | 78.8 (3.5) | 0.100 |
| Medications | |||
| Aspirin | 12 | 14 | 0.591 |
| β Blockers | 7 | 8 | 1.000 |
| Calcium channel blockers | 10 | 13 | 0.388 |
| Nitrates | 8 | 4 | 0.264 |
| Statins | 6 | 6 | 1.000 |
-
Results are presented as mean (SEM).
